Skip to content

ATOS - ATOSSA THERAPEUTICS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Atossa Genetics Inc

ATOS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ATOSAtossa Genetics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $19.35
52-wk low: $1.70
Prev close: $10.78
Mkt cap: $26.3M
Fwd P/E: 7.0x
Beta: 1.25

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$756K

JS
Jim Simons
Q2 2026 13F
$255K
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 7, 2026

Earnings came in 8.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 7.04
Market cap: $26M

Valuation

P/S1872.06
P/B0.96

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ATOS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $26.35M
Beta: 1.25

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1872.1x

P/B

1.0x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-89.2%

$90K

position

MW

Marshall Wace

Q4 2025 13F

$17K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for ATOS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.95+8.7%

-$1.04 expected

Next report

What the street expects next

-89.2%

ROA-50.7%

Growth

Beta1.25